← back to search

Hossein Danafar

Gene Therapy Laboratory · FR
Area of research
Biomaterials · Biomedical Engineering
Research interest
Research interests include Coronavirus disease 2019 (COVID-19), Pandemic, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus, Medicine, and Caprolactone.
h-index
citations
170
works
3
NIH funding
primary concept
email

Recent publications

Nanotechnology Against The Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2): Diagnosis, Treatment, Therapy and Future Perspectives
Nanomedicine 2021cited by 76position: middledoi
Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model
Journal of Materials Chemistry B 2021cited by 37position: lastdoi
Poly(caprolactone)–poly(ethylene glycol)–poly(caprolactone) (PCL–PEG–PCL) nanoparticles: a valuable and efficient system for in vitro and in vivo delivery of curcumin
RSC Advances 2016cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ali Ramazani · University of Michigan–Ann Arbor2 papers (2016–2021)Hamed Nosrati · Gene Therapy Laboratory2 papers (2021–2021)Taras Kavetskyy · Institute for Health Metrics and Evaluation2 papers (2021–2021) · 2 papers (2021–2021)Fatemeh Abhari · Gene Therapy Laboratory1 papers (2021–2021) · 1 papers (2016–2016) · 1 papers (2016–2016) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2016–2016) · 1 papers (2021–2021)Yasamin Baghdadchi · Gene Therapy Laboratory1 papers (2021–2021) · 1 papers (2021–2021)Ali Mohammadi · Aarhus University1 papers (2021–2021)Aziz Eftekhari · INTI International University1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Thomas J. Webster · Wenzhou University1 papers (2021–2021) · 1 papers (2021–2021)Yavuz Nuri Ertaş · Center for Drug Evaluation and Research1 papers (2021–2021)